December - January,2020
Vaccines and the road ahead
First, the good news! The U.S. biotech company, Moderna, has reported that its RNAbased vaccine is more than 94 per cent effective in preventing COVID-19. Moderna released figures suggesting that its vaccine is likely to prevent severe COVID-19 infections, an aspect which was not clear from the other developers’ announcements.
